Bioorganic & Medicinal Chemistry 2008-04-01

Design and synthesis of dual inhibitors of HIV reverse transcriptase and integrase: introducing a diketoacid functionality into delavirdine.

Zhengqiang Wang, Robert Vince

Index: Bioorg. Med. Chem. 16(7) , 3587-95, (2008)

Full Text: HTML

Abstract

Cost and toxicity problems associated with highly active antiretroviral therapy (HAART) in HIV/AIDS treatment could be alleviated by using designed multiple ligands (DMLs). Dual inhibitors of HIV reverse transcriptase (RT) and integrase (IN) were rationally designed by introducing a diketoacid (DKA) functionality into the tolerant C-5 site of RT inhibitor delavirdine. The resulting compounds all demonstrate good activity against both RT and IN in enzymatic assays and HIV in cell-based assay, whereas their C-7 regioisomers are all inactive in these assays. Balanced activities were observed with C-3 halogenated inhibitors.

Related Compounds

  • DELAVIRDINE...

Related Articles:

Colloid formation by drugs in simulated intestinal fluid.

2010-05-27

[J. Med. Chem. 53 , 4259-65, (2010)]

Methylmethacrylate–sulfopropylmethacrylate nanoparticles with surface RMP-7 for targeting delivery of antiretroviral drugs across the blood–brain barrier

2012-01-01

[Colloids Surf. B Biointerfaces 90 , 75-82, (2012)]

Synthesis and biological evaluation of pyridazine derivatives as novel HIV-1 NNRTIs.

2013-04-01

[Bioorg. Med. Chem. 21(7) , 2128-34, (2013)]

Solid lipid nanoparticles comprising internal Compritol 888 ATO, tripalmitin and cacao butter for encapsulating and releasing stavudine, delavirdine and saquinavir.

2011-12-01

[Colloids Surf. B Biointerfaces 88(2) , 682-90, (2011)]

Modifying the diffusion layer of soluble salts of poorly soluble basic drugs to improve dissolution performance.

2010-10-04

[Mol. Pharm. 7(5) , 1441-9, (2010)]

More Articles...